St Marys University
London, TW1 4SX, United Kingdom
NCT Number: NCT04446754
This study investigates the association of genetic effects of rs7903146 and dietary intake on type 2 Diabetes Mellitus (T2DM) risk in a healthy population. T2DM risk was assessed through glycated haemoglobin (HbA1c) concentration in 73 subjects. Dietary intake was assessed using a validated food frequency questionnaire (FFQ).
Looking for future studies?
Notify Me18 year–64 year
All sexes
Observational
London, TW1 4SX, United Kingdom
Type 2 diabetes mellitus (T2DM) is a global epidemic linked to 1.6 million deaths in 2016. Diet, lifestyle and environment contribute significantly to T2DM-risk. Genome-wide association studies identify the transcription factor 7-like 2 (TCF7L2) rs7903146 (C/T) gene as one of the most important associated with T2DM-risk. The T-allele is associated with a two-fold increase in relative risk of T2DM across different populations. However, most studies associating genetic effects of dietary intake on rs7903146 and T2DM-risk utilised volatile instantaneous measures of glucose(5) and focussed on individual macronutrients. Understanding the association of rs7903146 and overall macronutrient intake using a stable blood homeostasis marker may provide a fuller insight into T2DM-risk.
The study included data for all variables (participant characteristics: sex (female/male), age (years), height (cm), weight (kg), body mass index (BMI) (kg/m2), body fat percentage (%), fat mass (kg), lean mass (kg), waist/hip (ratio), dietary intake, HbA1c (mmol/mol and %) and physical activity (hours/week). All data was collected at St Mary's University between April to July 2019. Participants was genotyped and allocated into two groups: major allele (C) homozygote versus minor allele (T) homozygote plus heterozygote. T2DM-risk was assessed through their value of HbA1c and participants were classified as follows: normal (<42mmol/mol/ <6.0%), pre-diabetic (42 to 47 mmol/mol/ 6.0% to 6.4%), diabetes (48mmol/mol /6.5% or over).
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Eligibility criteria required healthy adults free from metabolic condition and free from medication affecting glycated haemoglobin levels.
Exclusion criteria
Individuals with HbA1c levels ≥48 mmol/mol or ≥6.5% were excluded due to a classification as T2DM (WHO, 2011).
Time frame: 3 months
salivary (1-ml) DNA for genotype TCF7L2 gene (rs7903146 SNP)
Time frame: 3 months
capillary blood collected (via the ears or fingers) using a Microvette CB Lithium Heparin tube (SARSTEDT AG & C0., Nümbrecht, Germany)
Time frame: 3 months
Dietary intake estimated using The European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk (food frequency questionnaire)
Time frame: 3 months
Body weight in kg measured by bioelectrical impedance analysis using a 0.5kg clothing offset
Time frame: 3 months
Waist measurement was taken midway between iliac crest and lowest rib
Time frame: 3 months
Hip circumference was measured over the greater trochanters at their widest point (nearest 0.1cm)
Time frame: 3 months
Subject height was recorded to the nearest 0.1-cm via stadiometer
Time frame: 3 months
Assessed through Physical Activity Readiness Questionnaire (PAR-Q)
Time frame: 3 months
Measured in kg and percentage (%) measured by bioelectrical impedance analysis
Time frame: 3 months
Measured in kg and percentage (%) measured by bioelectrical impedance analysis
St Mary's University College
Other
The Association Between TCF7L2 rs7903146, Diet and Type 2 Diabetes Mellitus Risk
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06160258
Behavior, Behavior, Animal
Spokane, Washington, United States
View Trial DetailsNCT05394779
Behavior, Behavior, Animal
Milan, Italy
View Trial DetailsNCT04241133
Behavior, Behavior, Animal
Bozeman, Montana, United States
View Trial DetailsNCT03941392
Behavior, Behavior, Animal
Granada, Spain
View Trial Details